Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions: Early report.
作者信息
Pitlick Mitchell M, Sitek Andrea N, Kinate Susan A, Joshi Avni Y, Park Miguel A
机构信息
Division of Allergic Diseases, Mayo Clinic, Rochester, Minnesota.
Division of Allergic Diseases, Mayo Clinic, Scottsdale, Arizona.
出版信息
Ann Allergy Asthma Immunol. 2021 Jun;126(6):735-738. doi: 10.1016/j.anai.2021.03.012. Epub 2021 Mar 26.
Abstract
摘要
相似文献
1
Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions: Early report.聚乙二醇和聚山梨酯皮肤试验在评估2019冠状病毒病疫苗反应中的应用：早期报告
Ann Allergy Asthma Immunol. 2021 Jun;126(6):735-738. doi: 10.1016/j.anai.2021.03.012. Epub 2021 Mar 26.
2
Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.美国过敏、哮喘与免疫学会2019冠状病毒病疫苗特别工作组见解：对mRNA新型冠状病毒疫苗的过敏反应
Ann Allergy Asthma Immunol. 2021 Apr;126(4):319-320. doi: 10.1016/j.anai.2021.01.017. Epub 2021 Jan 23.
3
Allergic Reactions to COVID-19 Vaccines: An Allergist's Perspective.对新冠疫苗的过敏反应：过敏症专科医生的观点
Acta Med Port. 2021 Mar 1;34(3):243. doi: 10.20344/amp.15803. Epub 2021 Feb 5.
4
Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.新型mRNA新冠疫苗在重度过敏患者中的安全性
J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):180-181. doi: 10.18176/jiaci.0683. Epub 2021 Mar 2.
5
Safety outcomes of SARS-CoV-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate.有首剂反应史或对聚乙二醇或聚山梨酯过敏的儿科患者接种新型冠状病毒2疫苗的安全性结果。
J Allergy Clin Immunol Pract. 2022 Aug;10(8):2172-2175.e1. doi: 10.1016/j.jaip.2022.05.035. Epub 2022 Jul 13.
6
Safe Administration of SARS-CoV-2 Vaccine After Desensitization to a Biologic Containing Polysorbate 80 in a Patient With Polyethylene Glycol-Induced Severe Anaphylaxis and Sensitization to Polysorbate 80.在一名对聚乙二醇诱导的严重过敏反应且对聚山梨醇酯80敏感的患者中，对含聚山梨醇酯80的生物制品脱敏后安全接种新型冠状病毒2疫苗。
J Investig Allergol Clin Immunol. 2023 Apr 18;33(2):151-153. doi: 10.18176/jiaci.0830. Epub 2022 May 31.
7
Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics.2019 年冠状病毒病疫苗在有报告称对含聚乙二醇和聚山梨酯的治疗药物有反应的患者中的给药。
Ann Allergy Asthma Immunol. 2022 Jul;129(1):88-94.e1. doi: 10.1016/j.anai.2022.03.006. Epub 2022 Mar 12.
8
Polyethylene glycol and polysorbate testing in 12 patients before or after coronavirus disease 2019 vaccine administration.在12名患者中于2019冠状病毒病疫苗接种前后进行聚乙二醇和聚山梨酯检测。
Ann Allergy Asthma Immunol. 2022 Jan;128(1):99-101. doi: 10.1016/j.anai.2021.10.009. Epub 2021 Oct 12.
9
Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination.评估疑似对聚乙二醇和聚山梨酯过敏的儿科患者在 mRNA SARS-CoV2 疫苗接种前的情况。
Allergol Immunopathol (Madr). 2023 May 1;51(3):174-180. doi: 10.15586/aei.v51i3.800. eCollection 2023.
10
Specialist allergy advice allows vaccination in patients with reactions to COVID-19 vaccines.专科过敏症建议允许对新冠疫苗有反应的患者接种疫苗。
Clin Exp Allergy. 2022 Mar;52(3):465-469. doi: 10.1111/cea.14069. Epub 2021 Dec 6.
引用本文的文献
1
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302).在一项1期随机开放标签临床试验（HVTN 302）中，研究性HIV-1 BG505 MD39.3三聚体mRNA疫苗接种后慢性荨麻疹的高发生率
Ann Intern Med. 2025 Jul;178(7):963-974. doi: 10.7326/ANNALS-24-02701. Epub 2025 Apr 29.
2
A comprehensive review of oral microenvironment changes and orofacial adverse reactions after COVID-19 vaccination: The good, the bad, and the ugly.新冠疫苗接种后口腔微环境变化及口面部不良反应的综合综述：好的、坏的与难看的。
Health Sci Rep. 2024 Mar 13;7(3):e1967. doi: 10.1002/hsr2.1967. eCollection 2024 Mar.
3
Absence of Anaphylactic Reactions to Injection of Hemoglobin Vesicles (Artificial Red Cells) to Rodents.对啮齿动物注射血红蛋白囊泡（人工红细胞）未出现过敏反应。
ACS Omega. 2023 Dec 19;9(1):1904-1915. doi: 10.1021/acsomega.3c08641. eCollection 2024 Jan 9.
4
Polyethylene Glycol and Polysorbate 80 Skin Tests in the Context of an Allergic Risk Assessment for Hypersensitivity Reactions to Anti-SARS-CoV-2 mRNA Vaccines.在针对抗SARS-CoV-2 mRNA疫苗超敏反应的过敏风险评估背景下进行聚乙二醇和聚山梨酯80皮肤试验
Vaccines (Basel). 2023 Apr 28;11(5):915. doi: 10.3390/vaccines11050915.
5
Vaccine confidence among those living with allergy during the COVID pandemic (ACCORD): A scoping review.新冠疫情期间过敏症患者的疫苗信心（ACCORD）：一项范围综述
J Allergy Clin Immunol Glob. 2023 May;2(2):100079. doi: 10.1016/j.jacig.2023.100079. Epub 2023 Feb 8.
6
COVID-19 vaccine allergy advice and guidance: The experience of a UK tertiary referral centre.2019冠状病毒病疫苗过敏建议与指南：英国一家三级转诊中心的经验
World Allergy Organ J. 2023 Jan;16(1):100740. doi: 10.1016/j.waojou.2022.100740. Epub 2023 Jan 7.
7
Study of Excipients in Delayed Skin Reactions to mRNA Vaccines: Positive Delayed Intradermal Reactions to Polyethylene Glycol Provide New Insights for COVID-19 Arm.mRNA疫苗延迟皮肤反应中辅料的研究：对聚乙二醇的阳性延迟皮内反应为新冠疫苗接种部位反应提供新见解
Vaccines (Basel). 2022 Nov 30;10(12):2048. doi: 10.3390/vaccines10122048.
8
Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions.辉瑞-生物科技（BNT162b2）、莫德纳（mRNA-1273）COVID-19 mRNA 疫苗与过敏反应。
J Natl Med Assoc. 2022 Dec;114(6):601-612. doi: 10.1016/j.jnma.2022.08.003. Epub 2022 Oct 28.
9
Recent developments in the immunopathology of COVID-19.COVID-19 免疫病理学的最新进展。
Allergy. 2023 Feb;78(2):369-388. doi: 10.1111/all.15593. Epub 2022 Dec 5.
10
Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A systematic review and meta-analysis.COVID-19 疫苗过敏反应疫苗和疫苗赋形剂检测的诊断准确性：系统评价和荟萃分析。
Allergy. 2023 Jan;78(1):71-83. doi: 10.1111/all.15571. Epub 2022 Nov 23.
本文引用的文献
1
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.2020年12月14日至2021年1月18日美国接种mRNA新冠疫苗后发生过敏反应的报告
JAMA. 2021 Mar 16;325(11):1101-1102. doi: 10.1001/jama.2021.1967.
2
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach.mRNA 疫苗预防 COVID-19 疾病和报告的过敏反应：当前证据和建议方法。
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1423-1437. doi: 10.1016/j.jaip.2020.12.047. Epub 2020 Dec 31.
3
Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs.药物超敏反应评估与管理实用指南：特定药物
J Allergy Clin Immunol Pract. 2020 Oct;8(9S):S16-S116. doi: 10.1016/j.jaip.2020.08.006.
4
Polyethylene Glycol-Induced Systemic Allergic Reactions (Anaphylaxis).聚乙二醇引起的全身性过敏反应（过敏症）。
J Allergy Clin Immunol Pract. 2021 Feb;9(2):670-675. doi: 10.1016/j.jaip.2020.09.029. Epub 2020 Oct 1.
5
Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized.对聚乙二醇和聚山梨酯的即刻过敏反应：比我们认识到的更为常见。
J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1533-1540.e8. doi: 10.1016/j.jaip.2018.12.003. Epub 2018 Dec 14.
6
Immediate-type hypersensitivity to polyethylene glycols: a review.对聚乙二醇的速发型超敏反应：综述
Clin Exp Allergy. 2016 Jul;46(7):907-22. doi: 10.1111/cea.12760.
7
Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study.布莱顿协作组织病例定义能否用于提高预防接种不良反应（AEFI）报告的质量？以过敏反应作为案例研究。
Vaccine. 2010 Jun 17;28(28):4487-98. doi: 10.1016/j.vaccine.2010.04.041. Epub 2010 Apr 29.
Zotero 插件